HON
53
-7
AXP
57
-3
PLD
28
-4
OI
37
-6
RL
59
-4
IBM
50
-3
WMB
60
-2
WFC
69
-5
MMM
45
-4
FFIV
56
-4
PEP
53
-3
SNA
45
-4
GM
49
-3
BBY
43
-3
GLW
42
-3
PPL
82
2
VFC
45
-4
XRX
28
-3
MAS
50
-10
EMN
42
-3
HON
53
-7
AXP
57
-3
PLD
28
-4
OI
37
-6
RL
59
-4
IBM
50
-3
WMB
60
-2
WFC
69
-5
MMM
45
-4
FFIV
56
-4
PEP
53
-3
SNA
45
-4
GM
49
-3
BBY
43
-3
GLW
42
-3
PPL
82
2
VFC
45
-4
XRX
28
-3
MAS
50
-10
EMN
42
-3
Financhill
Back

Integra Lifesciences Holdings Stock Predictions

Meet the founder that's revolutionizing smartphones

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
13

IART
Integra Lifesciences Holdings

Last Price:
$21.98
Seasonality Move:
2.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Integra Lifesciences Holdings Stock Forecast

  • Over the next 52 weeks, Integra Lifesciences Holdings has on average historically risen by 16.5% based on the past 29 years of stock performance.
  • Integra Lifesciences Holdings has risen higher in 16 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.17%
  • Is Integra Lifesciences Holdings Stock Undervalued?
    The current Integra Lifesciences Holdings [IART] share price is $21.69. The Score for IART is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • IART is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Integra Lifesciences Holdings Stock Go Up Next Year?

  • Over the next 52 weeks, Integra Lifesciences Holdings has on average historically risen by 16.5% based on the past 29 years of stock performance.

Integra Lifesciences Holdings Stock Rating

Sell
13
Integra Lifesciences Holdings (IART) is a Sell

Is Integra Lifesciences Holdings overpriced?

  • Integra Lifesciences Holdings has risen higher in 16 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.17%

Integra Lifesciences Holdings Stock Price History

Is IART stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IART is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
integralife.com

52-Week Data

52-Week High:
35.49
52-Week Low:
16.81

Prediction Charts

Market Cap:
1.8B
Price in USD:
21.69
Volume:
464K
Beta:
0.94

Technical Analysis

SMA50:
23.76
SMA100:
23.48
SMA200:
23.38
52-Wk Change:
-38.44%

Stock Predictions

  • Is Integra Lifesciences Holdings stock public?
    Yes, Integra Lifesciences Holdings is a publicly traded company.
  • What is the Integra Lifesciences Holdings stock quote today?
    The Integra Lifesciences Holdings stock price is 21.69 USD today.
  • How to buy Integra Lifesciences Holdings stock online?
    You can buy Integra Lifesciences Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-11 22.76 23.95 24.12 22.46
Mar-12 23.89 22.24 24.37 22.01
Mar-13 22.20 22.27 22.73 22.12
Mar-14 22.32 22.35 22.89 22.05
Mar-17 22.26 23.12 23.27 22.01
Mar-18 23.12 22.62 23.21 22.47
Mar-19 22.53 22.82 22.95 21.95
Mar-20 22.59 22.71 23.16 22.30
Mar-21 22.40 22.49 22.75 22.21
Mar-24 22.88 22.64 22.96 22.36
Mar-25 22.54 22.18 22.83 21.89
Mar-26 22.09 21.82 22.35 21.49
Mar-27 21.80 22.01 22.20 21.55
Mar-28 21.92 21.69 22.08 21.45

Integra Lifesciences Holdings Earnings

Integra Lifesciences Holdings Earnings Report: Per Share Integra Lifesciences Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.

Integra Lifesciences Holdings Forecast Revenue Growth

Integra Lifesciences Holdings Stock Analysis: Historical quarterly revenues per share for Integra Lifesciences Holdings and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.01 per share, and an increase next year of $0.25 per share.

* Integra Lifesciences Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.